06018cam a2200613 i 4500 22440028 OSt 20230214092423.0 220222s2018 enka b 001 0 eng c 2021277744 GBB8B9472 bnb 101735148 DNLM 018921247 Uk 0128144237 (OCoLC)on1049562445 NLM eng NLM rda YDX OCLCF UKMGB Z5F OCLCO OCLCA BDF OCLCO DLC pcc RS200 .D66 2018 Dosage form design considerations. Volume I / edited by Rakesh K. Tekade. London, United Kingdom ; San Diego, CA, United States : Academic Press/Elsevier, [2018] xvii, 861 p. text txt rdacontent unmediated n rdamedia volume nc rdacarrier Advances in pharmaceutical product development and research series 1. Preformulation in Drug Research and Pharmaceutical product development 2. Physicochemical aspects to be considered in pharmaceutical product development 3. Role of physicochemical parameters on drug absorption and their implication in pharmaceutical product development 4. Physiologic factors related to drug absorption 5. Physicochemical, pharmaceutical, and biological considerations in GIT absorption of drugs 6. Influence of drug properties and routes of drug administration on the design of controlled release system 7. Stability and degradation studies for drug and drug product 8. First-pass metabolism considerations in pharmaceutical product development 9. Dissolution profile consideration in pharmaceutical product development 10. Drug disposition considerations in pharmaceutical product 11. Protein and tissue binging: implication on pharmacokinetic parameters 12. Preformulation studies of drug substances, protein, and Peptides: Role in drug discovery and pharmaceutical product development 13. Role of salt selection in drug discovery and development 14. Drug complexation: implications in drug solubilization and oral bioavailability enhancement 15. Solubility and solubilization approaches in pharmaceutical product development 16. Rheology and its implications on performance of liquid dosage forms 17. Micromeritics in pharmaceutical product development 18. Four stages of pharmaceutical product development: preformulation, prototype development and scale-up, biological aspects, and commercialization 19. Scale-up studies in pharmaceutical products development 20. Manipulation of physiological processes for pharmaceutical product development 21. Impact of pharmaceutical product quality on clinical efficacy 22. Formulation additives used in pharmaceutical products: emphasis on regulatory perspectives and GRAS. Includes bibliographical references and index. 1. Preformulation in Drug Research and Pharmaceutical product development 2. Physicochemical aspects to be considered in pharmaceutical product development 3. Role of physicochemical parameters on drug absorption and their implication in pharmaceutical product development 4. Physiologic factors related to drug absorption 5. Physicochemical, pharmaceutical, and biological considerations in GIT absorption of drugs 6. Influence of drug properties and routes of drug administration on the design of controlled release system 7. Stability and degradation studies for drug and drug product 8. First-pass metabolism considerations in pharmaceutical product development 9. Dissolution profile consideration in pharmaceutical product development 10. Drug disposition considerations in pharmaceutical product 11. Protein and tissue binging: implication on pharmacokinetic parameters 12. Preformulation studies of drug substances, protein, and Peptides: Role in drug discovery and pharmaceutical product development 13. Role of salt selection in drug discovery and development 14. Drug complexation: implications in drug solubilization and oral bioavailability enhancement 15. Solubility and solubilization approaches in pharmaceutical product development 16. Rheology and its implications on performance of liquid dosage forms 17. Micromeritics in pharmaceutical product development 18. Four stages of pharmaceutical product development: preformulation, prototype development and scale-up, biological aspects, and commercialization 19. Scale-up studies in pharmaceutical products development 20. Manipulation of physiological processes for pharmaceutical product development 21. Impact of pharmaceutical product quality on clinical efficacy 22. Formulation additives used in pharmaceutical products: emphasis on regulatory perspectives and GRAS Drugs Dosage forms. Drugs Design. Drug development. Drug delivery systems. Dosage Forms Drug Compounding Drug Design Drug Delivery Systems Médicaments Formes pharmaceutiques. Médicaments Conception. Médicaments Développement. Systèmes d'administration de médicaments. Drug delivery systems. fast (OCoLC)fst00898667 Drug development. fast (OCoLC)fst00898670 Drugs Design. fast (OCoLC)fst00898790 Drugs Dosage forms. fast (OCoLC)fst00898801 Formes pharmaceutiques. ram (FrPBN)11962013 Médicaments Mise au point. ram (FrPBN)13177938 Médicaments Composition chimique. ram (FrPBN)12500373 Tekade, Rakesh K., editor. ebook version : 9780128144244 Advances in pharmaceutical product development and research series. 7 cbc pccadap 2 ncip 20 y-gencatlg lcc BK 19988 19987 0 0 lcc 0 KABU KABU 2023-02-14 19380.00 0 RS200 .D66 2018 c.1 34679 2023-02-14 00:00:00 2023-02-14 BK